The global immunoprecipitation market is expected to grow in the upcoming years. Increase in the research and development activities in the life science sector is boosting the growth of immunoprecipitation market. Immunoprecipitation is the procedure used for separation of specified protein from the solution. It uses antibody which can bind with the protein.
The Immunoprecipitation process is in rise due to increase in autoimmune disease cases which needs the antibody-antigen interaction for testing. Increased applications of immunoprecipitation processes in disorders such as cancer, cardiovascular diseases are boosting the growth of immunoprecipitation market.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID-19 is expected to have significant impact on Immunoprecipitation Market.
Top Impacting factors:
- Factors such as rise in detection of antigens which are found in autoimmune diseases can drive the growth of immunoprecipitation market in future. Increase in the research and development made in life sciences and genomics, immunotherapy and microbiome has resulted in the growth of the market
- Advancements made in the immunoprecipitation techniques such as chromatin immunoprecipitation and chIP-seq have boosted immunoprecipitation market growth.
- Rise in funding from the government and non- government organizations for research and development purpose in next generation DNA sequencing and genomics is rising the growth of Immunoprecipitation market.
- Restrain factors such as limitations in sample size, differences seen in content of lipid can hamper the growth of immunoprecipitation market.
New Product Launch / News:
- In April 2019, GenScript Biotech Corporation made strategic collaboration with REMD Bio therapeuticsInc., to develop renewed immunotherapy drugs using bi-specific antibodies.
- In 2018, Thermo Fisher Scientific inaugurated new bioprocess design center in Shanghai, China, to connect and collaborate with biologic developers to design optimal bioprocessing solutions.
Key benefits of the report:
- This study presents the analytical depiction of the GlobalImmunoprecipitation Marketalong with the current trends and future estimations to determine the investments.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Immunoprecipitation Market share.
- The current market is quantitatively analyzed to highlight theImmunoprecipitation Market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed Immunoprecipitation Marketanalysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Immunoprecipitation MarketReport:
- What are the leading market players active inImmunoprecipitation Market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
- What Segments and region will drive the market growth & why?
- What are the major end users for immunoprecipitation products?
Immunoprecipitation Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Takara Bio Inc, Abbkine Scientific Co Ltd, Abbkine Scientific Co., Ltd, Cell Signaling Technology, Inc., Merck KGaA, GenScript Biotech Corporation, Geno Technology Inc, Bio-Rad Laboratories, Abcam plc., Thermo Fisher Scientific Inc. |
Loading Table Of Content...
